Skip to main content
Midas Edge

Equillium, Inc.

For the period ended Mar 31, 2025. Filed May 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

EQ$1.46-3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders' Equity

(In thousands, except share data)

Additional · AccumulatedOther · Total
Common Stock · Paid-in · Comprehensive · Accumulated · Stockholders'
Shares · Amount · Capital · Income · Deficit · Equity
Balance at December 31, 202335,254,752$3$208,170$140$(185,740)$22,573
Stock-based compensation expense--972--972
Comprehensive income---283-283
Net loss----(2,734)(2,734)
Balance at March 31, 202435,254,752$3$209,142$423$(188,474)$21,094
Additional · AccumulatedOther · Total
Common Stock · Paid-in · Comprehensive · Accumulated · Stockholders'
Shares · Amount · Capital · Income · Deficit · Equity
Balance at December 31, 202435,557,563$3$212,084$781$(193,807)$19,061
Stock-based compensation expense--621--621
Exercise of stock options52,34438--38
Issuance of common stock under ATM, net of issuance costs109,410-(438)--(438)
Comprehensive loss---(50)-(50)
Net loss----(8,654)(8,654)
Balance at March 31, 202535,719,317$3$212,305$731$(202,461)$10,578
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.